| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |